COMMUNIQUÉS West-GlobeNewswire

Pliant Therapeutics Presents Clinical and Preclinical Data at the American Thoracic Society International Conference
21/05/2025
SOUTH SAN FRANCISCO, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that the Company led oral and poster presentations of clinical and preclinical data this week as [...]
Immix Biopharma to Host KOL Event to Discuss NXC-201 Clinical Data Presented at ASCO 2025 in relapsed/refractory AL Amyloidosis
21/05/2025
– Virtual KOL Event Tuesday, June 3, 2025 3:00pm ET – – Attend the event here: https://lifescievents.com/event/immix-asco – LOS ANGELES, CA, May 21, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company [...]
MediPharm Labs Alerts Shareholders to Allegations Made Against Regan McGee in Multiple Litigation Filings
21/05/2025
TORONTO, May 21, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (" MediPharm " or the " Company "), a pharmaceutical company specialized in precision-based cannabinoids, today alerted its shareholders to [...]
Sharps Technology to Present at the Aegis Capital Corp. 2025 Virtual Conference on May 22nd
21/05/2025
Presentation to be webcast at 1:00 p.m. ET NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company [...]
Joule Health & Wellbeing Offers Same-Day Stress Support, Providing a Scalable Solution for HR Leaders Addressing Burnout
21/05/2025
Spokane, WA , May 21, 2025 (GLOBE NEWSWIRE) -- In recognition of Mental Health Awareness Month, Joule Health & Wellbeing has expanded its offerings to include same-day stress support —a scalable solution designed to [...]
Ipsen S.A. - Annual General Meeting held on 21 May 2025
21/05/2025
Annual General Meeting of Ipsen S.A. held on 21 May 2025 All the resolutions submitted to the shareholders’ vote have been adopted PARIS, FRANCE, 21 May 2025 - Ipsen (Euronext: IPN; ADR: IPSEY) announces today that the [...]
Ipsen S.A. - Assemblée Générale Annuelle du 21 mai 2025
21/05/2025
Information réglementée Destiné uniquement aux médias internationaux et à la communauté d’investisseurs Assemblée Générale Annuelle d’Ipsen S.A. du 21 mai 2025 Toutes les résolutions soumises au vote des actionnaires [...]
OSE Immunotherapeutics Announces Strategic Collaboration to Pioneer Novel mRNA Technologies
21/05/2025
OSE Immunotherapeutics Announces Strategic Collaboration to Pioneer Novel mRNA Technologies OSE Immunotherapeutics to lead French consortium with Inside Therapeutics and MiNT Laboratory (University of Angers) secures €1 [...]
OSE Immunotherapeutics annonce une collaboration stratégique sur des technologies pionnières dans le domaine de l’ARNm
21/05/2025
OSE Immunotherapeutics annonce une collaboration stratégique sur des technologies pionnières dans le domaine de l’ARNm OSE Immunotherapeutics, chef de file d’un consortium français aux côtés d’Inside Therapeutics et du [...]
Combined General Meeting of May 21, 2025
21/05/2025
Press Release - Approval of all resolutions submitted by the Board of Directors, including the unconsolidated and consolidated financial statements for the year 2024 - Paris – May 21, 2025 – The Combined General [...]
Assemblée Générale Mixte du 21 mai 2025
21/05/2025
Communiqué de presse - Approbation de l’ensemble des résolutions proposées par le Conseil d’administration, y compris les comptes sociaux et les comptes consolidés de l’exercice 2024 - Paris – Le 21 mai 2025 - L’ [...]
Sandoz launches Pyzchiva® autoinjector, first commercially available in Europe for ustekinumab biosimilars
21/05/2025
MEDIA RELEASE Pyzchiva® first ustekinumab biosimilar in Europe commercially available in pre-filled pen (autoinjector), offering improved self-administration experience for better treatment adherence and quality of life [...]
Genmab to Participate in a Fireside Chat at the 2025 Jefferies Global Health Care Conference
21/05/2025
Media Release COPENHAGEN, Denmark; May 21, 2025 Genmab A/S (Nasdaq: GMAB ) a nnounced today that its Chief Development Officer Judith Klimovsky will participate in a fireside chat at the 2025 Jefferies Global Health [...]
Spinal Rehab & Sports Medicine Celebrates Two-Year Milestone of Dr. Josh Meyer, D.C.—Extending a Legacy of Excellence in Austin, TX
21/05/2025
AUSTIN, Texas, May 21, 2025 (GLOBE NEWSWIRE) -- Spinal Rehab & Sports Medicine , a cornerstone of sports injury recovery and performance care in Austin for over 25 years, proudly celebrates the two-year anniversary [...]
SPRINT® PNS Meets Primary Endpoint of Reduction in Head Pain in First Publication of Multicenter Prospective MONARCH™ Study
21/05/2025
CLEVELAND, May 21, 2025 (GLOBE NEWSWIRE) -- Today, SPR announced the publication of the MONARCH (Multicenter Occipital Neuralgia and Cervicogenic Headache) Study, which evaluates the use of 60-day SPRINT PNS treatment [...]
SynVivo Appoints Dr. Richard Eglen to Board of Directors
21/05/2025
HUNTSVILLE, Ala., May 21, 2025 (GLOBE NEWSWIRE) -- SynVivo , a pioneering organ-on-chip company developing advanced microfluidic platforms that replicate human tissue microenvironments for drug discovery, today [...]
Invivyd Commends FDA Focus on Contemporary Evidence In Evaluating Medical Interventions To Prevent COVID-19
21/05/2025
FDA acknowledges that the benefit of repeat doses of COVID-19 vaccine boosters for Americans is uncertain; the updated regulatory framework for COVID-19 vaccines articulated by the Agency generally aligns with recent [...]
GRI Bio to Participate in the Virtual Investor Closing Bell Series
21/05/2025
Live webcast on Wednesday, May 28 th at 4:00 PM ET LA JOLLA, CA, May 21, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of [...]
Globally Recognized Expert in Rare Autoimmune Neurologic Diseases, Dr. Benjamin Greenberg, Joins Trethera Scientific Advisory Board
21/05/2025
LOS ANGELES, May 21, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, announced today the [...]

Pages